Cancer immunotherapy: potential involvement of mediators
The description of a cell-free soluble anti-tumour factor by Carswell et al. in 1975 (Proc Natl Acad Sci USA, 72: 3666–3670) was followed by a long series of experimental and clinical investigations into the role of cell-free mediators in cancer immunotherapy. These investigations included research...
Main Author: | S. Ben-Efraim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1997-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629359791659 |
Similar Items
-
Probiotics as potentiators of cancer immunotherapy
by: Shireesh Apte -
Tumour-mediated immunosuppression of antigen presenting cells: a potential target for cancer immunotherapy
by: El Refaee, Mohamed
Published: (2013) -
Therapeutic cancer vaccines and combination immunotherapies involving vaccination
by: Nguyen T, et al.
Published: (2014-10-01) -
Lenalidomide mediated immune regulation in cancer immunotherapy
by: Cher Chang, et al.
Published: (2011) -
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
by: Zong Sheng Guo, et al.
Published: (2019-01-01)